Search results
6 lip 2021 · It will also determine the potential cost benefit of sunlight therapy (especially valuable in the LMIC setting) and potential benefit to maternal–child interaction provided by sunlight therapy, which could decrease separation between newborns and their mothers and therefore reduce interruptions to maternal–child bonding.
5 sie 2022 · ABM clinical protocol #22: guidelines for management of jaundice in the breastfeeding infant 35 weeks or more of gestation — revised.
The study showed that sunlight therapy may reduce rehospitalization rates within seven days of discharge for treatment for hyperbilirubinemia, but the evidence was very uncertain (RR 0.55, 95% CI 0.27 to 1.11; RD −0.04, −0.08 to 0.01; 1 study, 482 infants; very low-certainty evidence).
26 sie 2024 · This report outlines a standardized approach to the use of phototherapy consistent with the 2022 American Academy of Pediatrics (AAP) “Clinical Practice Guideline Revision for the Management of Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation.” 1
sunlight phototherapy (FSPT) can be as efficacious and safe as conventional intensive electric phototherapy (IEPT) for treatment of moderate-to-severe neonatal hyperbilirubinaemia in a simulated rural Nigerian setting. FSPT was efficacious on 116 (87·2%) of 133 treatment days and IEPT was efficacious on 135 (88·8%) of 152 treatment
Podcast: Sunlight for the prevention and treatment of hyperbilirubinemia in newborns. Some new-born babies will suffer from jaundice and there are several Cochrane reviews of possible ways to prevent or treat it. These were added to in July 2021 with a new review of the effects of sunlight.
8 sie 2024 · They conceptualised a blue light source of 420–480 nm wavelength and confirmed its effectiveness on reducing unconjugated bilirubin in icteric serum samples and in newborns with jaundice. For approximately 10 years, their knowledge and enthusiasm were met with ill-disguised disapproval of several colleagues.
